Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

Launched by STANFORD UNIVERSITY · Jun 26, 2012

Keywords

ClinConnect Summary

This clinical trial is studying the long-term effects of hematopoietic stem cell transplantation (HSCT), a treatment often used for blood-related conditions. The goal is to collect and analyze information about the health and well-being of children who have received a stem cell transplant. This research will help doctors understand what long-term issues these patients may face and how to prevent or address them in the future, which can lead to better care for both current and future patients.

To be eligible for this trial, participants should be scheduled to receive or have already received a stem cell transplant for any medical condition. They can be from any age up to 74 years old and should be receiving follow-up care at Lucile Packard Children's Hospital. Participants, or their parents or guardians, need to be able to give consent to join the study. Throughout the trial, participants can expect regular check-ups and assessments to monitor their health, providing valuable information to improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant is scheduled to receive OR has received a hematopoietic stem cell transplant (HSCT) for any condition.
• • Participant may have had a HSCT in another institution than Lucile Packard Children's Hospital (LPCH) yet has transferred follow-up long-term care to our institution and is being seen through the late-effects clinic from the Pediatric HSCT program.
• • Participant AND/OR parent/legally authorized representative is able to provide written informed consent and assent (as applicable) for participation.
• Exclusion Criteria:
• • Participant has relapsed from a malignant diagnosis post HSCT and is not being worked-up for a new HSCT.
• • Participant or patient's authorized guardian is unable to provide consent and assent